Condition
Bacillary Dysentery
Total Trials
4
Recruiting
1
Active
1
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
50%
1 of 2 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
3Total
P 1 (3)
Trial Status
Completed2
Recruiting1
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT05961059Phase 1Recruiting
InvaplexAR-Detox and DmLT Adjuvant in the Netherlands and Zambia
NCT02445963Phase 1Completed
Safety and Immunogenicity of Artificial Invaplex (Shigella Flexneri 2a InvaplexAR)
NCT02797236Phase 1Completed
SF2a-TT15 Conjugate Vaccine in Healthy Adult Volunteers
NCT01612572Unknown
A Registry Study on Xiyanping(a Chinese Medicine Injection) Used in Fifty Hospitals
Showing all 4 trials